Immunoblotting revealed that overexpression of wild-type CHIP suppressed hyperglycemia-activated p53, thereby inducing Sox2, Oct-4, and Nanog; however, the empty vector and neither of the CHIP mutants produced the desired effect (Fig. 2C-D). This evidence concerns the gene TP53 and Hyperglycemia.